{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T12:12:00Z","timestamp":1783771920353,"version":"3.55.0"},"publisher-location":"Cham","reference-count":117,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032121653","type":"print"},{"value":"9783032121660","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-12166-0_22","type":"book-chapter","created":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:17:12Z","timestamp":1783768632000},"page":"601-615","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lipid Remodeling and Metabolic Adaptation in Cancer Cell Membranes: A Platform for Membrane-Targeted Nanotherapy"],"prefix":"10.1007","author":[{"given":"Adriana","family":"Cruz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasco D. B.","family":"Bonif\u00e1cio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,12]]},"reference":[{"issue":"3","key":"22_CR1","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1021\/mp9002464","volume":"7","author":"L Albertazzi","year":"2010","unstructured":"Albertazzi L, Serresi M, Albanese A, Beltram F (2010) Dendrimer internalization and intracellular trafficking in living cells. Mol Pharm 7(3):680\u2013688. https:\/\/doi.org\/10.1021\/mp9002464","journal-title":"Mol Pharm"},{"key":"22_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10989-014-9430-z","volume":"21","author":"M Bacalum","year":"2015","unstructured":"Bacalum M, Radu M (2015) Cationic antimicrobial peptides cytotoxicity on mammalian cells: an analysis using therapeutic index integrative concept. Int J Pept Res Ther 21:47\u201355. https:\/\/doi.org\/10.1007\/s10989-014-9430-z","journal-title":"Int J Pept Res Ther"},{"key":"22_CR3","doi-asserted-by":"publisher","unstructured":"Barman P, Joshi S, Sharma S, Preet S, Sharma S, Saini A (2023) Strategic approaches to improvise peptide drugs as next generation therapeutics. Int J Pept Res Ther 29(61). https:\/\/doi.org\/10.1007\/s10989-023-10524-3","DOI":"10.1007\/s10989-023-10524-3"},{"issue":"13","key":"22_CR4","doi-asserted-by":"publisher","first-page":"7264","DOI":"10.3390\/ijms25137264","volume":"25","author":"LV Bauso","year":"2024","unstructured":"Bauso LV, La Fauci V, Muna\u00f2 S, Bonfiglio D, Armeli A, Maimone N et al (2024) Biological activity of natural and synthetic peptides as anticancer agents. Int J Mol Sci 25(13):7264. https:\/\/doi.org\/10.3390\/ijms25137264","journal-title":"Int J Mol Sci"},{"key":"22_CR5","doi-asserted-by":"publisher","first-page":"3809","DOI":"10.1007\/s00018-017-2604-z","volume":"74","author":"AA Baxter","year":"2017","unstructured":"Baxter AA, Lay FT, Poon IKH, Kvansakul M, Hulett MD (2017) Tumor cell membrane-targeting cationic antimicrobial peptides: Novel insights into mechanisms of action and therapeutic prospects. Cell Mol Life Sci 74:3809\u20133825. https:\/\/doi.org\/10.1007\/s00018-017-2604-z","journal-title":"Cell Mol Life Sci"},{"key":"22_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2015.49","volume":"5","author":"S Beloribi-Djefaflia","year":"2016","unstructured":"Beloribi-Djefaflia S, Vasseur S, Guillaumond F (2016) Lipid metabolic reprogramming in cancer cells. Oncogenesis 5: e189. https:\/\/doi.org\/10.1038\/oncsis.2015.49","journal-title":"Oncogenesis"},{"issue":"12","key":"22_CR7","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.3390\/ijms19123871","volume":"19","author":"N Bernardes","year":"2018","unstructured":"Bernardes N, Fialho AM (2018) Perturbing the dynamics and organization of cell membrane components: a new paradigm for cancer-targeted therapies. Int J Mol Sci 19(12):3871. https:\/\/doi.org\/10.3390\/ijms19123871","journal-title":"Int J Mol Sci"},{"key":"22_CR8","doi-asserted-by":"publisher","first-page":"962","DOI":"10.1038\/cdd.2016.11","volume":"23","author":"RB Birge","year":"2016","unstructured":"Birge RB, Boeltz S, Kumar S, Carlson J, Wanderley J, Calianese D et al (2016) Phosphatidylserine is a global immunosuppressive signal in efferocytosis, infectious disease, and cancer. Cell Death Differ 23:962\u2013978. https:\/\/doi.org\/10.1038\/cdd.2016.11","journal-title":"Cell Death Differ"},{"key":"22_CR9","doi-asserted-by":"publisher","first-page":"3785","DOI":"10.1039\/B611813P","volume":"16","author":"U Boas","year":"2006","unstructured":"Boas U, Christensen JB, Heegaard PMH (2006) Dendrimers: design, synthesis and chemical properties. J Mater Chem 16:3785\u20133798. https:\/\/doi.org\/10.1039\/B611813P","journal-title":"J Mater Chem"},{"issue":"5","key":"22_CR10","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1016\/j.ccell.2016.04.003","volume":"29","author":"Y Cai","year":"2016","unstructured":"Cai Y, Crowther J, Pastor T, Abbasi Asbagh L, Baietti MF, De Troyer M et al (2016) Loss of chromosome 8p governs tumor progression and drug response by altering lipid metabolism. Cancer Cell 29(5):751\u2013766. https:\/\/doi.org\/10.1016\/j.ccell.2016.04.003","journal-title":"Cancer Cell"},{"issue":"11","key":"22_CR11","doi-asserted-by":"publisher","first-page":"1900132","DOI":"10.1002\/adtp.201900132","volume":"2","author":"MR Carvalho","year":"2019","unstructured":"Carvalho MR, Carvalho CR, Maia FR, Caballero D, Kundu SC, Reis RL et al (2019) Peptide-modified dendrimer nanoparticles for targeted therapy of colorectal cancer. Adv Ther 2(11):1900132. https:\/\/doi.org\/10.1002\/adtp.201900132","journal-title":"Adv Ther"},{"key":"22_CR12","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3389\/fchem.2018.00237","volume":"6","author":"PM Carvalho","year":"2018","unstructured":"Carvalho PM, Fel\u00edcio MR, Santos NC, Gon\u00e7alves S, Domingues MM (2018) Application of light scattering techniques to nanoparticle characterization and development. Front Chem 6:237. https:\/\/doi.org\/10.3389\/fchem.2018.00237","journal-title":"Front Chem"},{"issue":"9","key":"22_CR13","doi-asserted-by":"publisher","first-page":"2167","DOI":"10.3390\/ijms20092167","volume":"20","author":"D Casares","year":"2019","unstructured":"Casares D, Escrib\u00e1 PV, Rossell\u00f3 CA (2019) Membrane lipid composition: Effect on membrane and organelle structure, function and compartmentalization and therapeutic avenues. Int J Mol Sci 20(9):2167. https:\/\/doi.org\/10.3390\/ijms20092167","journal-title":"Int J Mol Sci"},{"issue":"32","key":"22_CR14","doi-asserted-by":"publisher","first-page":"10044","DOI":"10.1021\/ja048548j","volume":"126","author":"HT Chen","year":"2004","unstructured":"Chen HT, Neerman MF, Parrish AR, Simanek EE (2004) Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine. J Am Chem Soc 126(32):10044\u201310048. https:\/\/doi.org\/10.1021\/ja048548j","journal-title":"J Am Chem Soc"},{"key":"22_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.3892\/ijo.2020.5099","volume":"57","author":"W Chiangjong","year":"2020","unstructured":"Chiangjong W, Chutipongtanate S, Hongeng S (2020) Anticancer peptide: physicochemical property, functional aspect and trend in clinical application. Int J Oncol 57:678\u2013696. https:\/\/doi.org\/10.3892\/ijo.2020.5099","journal-title":"Int J Oncol"},{"key":"22_CR16","doi-asserted-by":"publisher","first-page":"114996","DOI":"10.1016\/j.biopha.2023.114996","volume":"164","author":"RK Chinnadurai","year":"2023","unstructured":"Chinnadurai RK, Khan N, Meghwanshi GK, Ponne S, Althobiti M, Kumar R (2023) Current research status of anti-cancer peptides: mechanism of action, production, and clinical applications. Biomed Pharmacother 164:114996. https:\/\/doi.org\/10.1016\/j.biopha.2023.114996","journal-title":"Biomed Pharmacother"},{"issue":"6","key":"22_CR17","doi-asserted-by":"publisher","first-page":"5430","DOI":"10.3390\/ijms24065430","volume":"24","author":"A Cruz","year":"2023","unstructured":"Cruz A, Barbosa J, Antunes P, Bonif\u00e1cio VDB, Pinto SN (2023) A glimpse into dendrimers integration in cancer imaging and theranostics. Int J Mol Sci 24(6):5430. https:\/\/doi.org\/10.3390\/ijms24065430","journal-title":"Int J Mol Sci"},{"issue":"2","key":"22_CR18","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3390\/antiox9020133","volume":"9","author":"A Cruz","year":"2020","unstructured":"Cruz A, Mota P, Ramos C, Pires RF, Mendes C, Silva JP, Nunes SC, Bonif\u00e1cio VDB, Serpa J (2020) Polyurea dendrimer folate-targeted manodelivery of L-buthionine sulfoximine as a tool to tackle ovarian cancer chemoresistance. Antioxidants 9(2):133. https:\/\/doi.org\/10.3390\/antiox9020133","journal-title":"Antioxidants"},{"key":"22_CR19","doi-asserted-by":"publisher","first-page":"7874","DOI":"10.1039\/D4CC00892H","volume":"60","author":"A Cruz","year":"2024","unstructured":"Cruz A, Pires RF, Raposinho P, Fernandes C, Paulo A, Bonif\u00e1cio VDB (2024) Ligand-free 99mTc-polyurea dendrimer complexes: nanoradiotheranostics targeting ovarian cancer. Chem Commun 60:7874\u20137877. https:\/\/doi.org\/10.1039\/D4CC00892H","journal-title":"Chem Commun"},{"issue":"9","key":"22_CR20","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1080\/17425247.2021.1912008","volume":"18","author":"N Desai","year":"2021","unstructured":"Desai N, Momin M, Khan T, Gharat S, Ningthoujam RS, Omri A (2021) Metallic nanoparticles as drug delivery system for the treatment of cancer. Expert Opin Drug Deliv 18(9):1261\u20131290. https:\/\/doi.org\/10.1080\/17425247.2021.1912008","journal-title":"Expert Opin Drug Deliv"},{"key":"22_CR21","doi-asserted-by":"publisher","first-page":"616979","DOI":"10.3389\/fmicb.2021.616979","volume":"12","author":"GS Dijksteel","year":"2021","unstructured":"Dijksteel GS, Ulrich MMW, Middelkoop E, Boekema BKHL (2021) Review: Lessons learned from clinical trials using antimicrobial peptides (AMPs). Front Microbiol 12:616979. https:\/\/doi.org\/10.3389\/fmicb.2021.616979","journal-title":"Front Microbiol"},{"issue":"19","key":"22_CR22","doi-asserted-by":"publisher","first-page":"1017","DOI":"10.2147\/ijn.s445333","volume":"2024","author":"Z Dong","year":"2024","unstructured":"Dong Z, Zhang X, Zhang Q, Tangthianchaichana J, Guo M, Du S et al (2024) Anticancer mechanisms and potential anticancer applications of antimicrobial peptides and their nano agents. Int J Nanomed 2024(19):1017\u20131039. https:\/\/doi.org\/10.2147\/ijn.s445333","journal-title":"Int J Nanomed"},{"key":"22_CR23","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1038\/s41573-018-0005-0","volume":"18","author":"I Ekladious","year":"2019","unstructured":"Ekladious I, Colson YL, Grinstaff MW (2019) Polymer\u2013drug conjugate therapeutics: advances, insights and prospects. Nat Rev Drug Discov 18:273\u2013294. https:\/\/doi.org\/10.1038\/s41573-018-0005-0","journal-title":"Nat Rev Drug Discov"},{"issue":"3","key":"22_CR24","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/s0168-3659(02)00087-1","volume":"81","author":"M El-Sayed","year":"2002","unstructured":"El-Sayed M, Ginski M, Rhodes C, Ghandehari H (2002) Transepithelial transport of poly(amidoamine) dendrimers across Caco-2 cell monolayers. J Control Release 81(3):355\u2013365. https:\/\/doi.org\/10.1016\/s0168-3659(02)00087-1","journal-title":"J Control Release"},{"issue":"1","key":"22_CR25","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1177\/0883911503018001","volume":"18","author":"M El-Sayed","year":"2003","unstructured":"El-Sayed M, Ginski M, Rhodes CA, Ghandehari H (2003) Influence of surface chemistry of poly(amidoamine) dendrimers on Caco-2 cell monolayers. J Bioact Compat Polym 18(1):7\u201322. https:\/\/doi.org\/10.1177\/0883911503018001","journal-title":"J Bioact Compat Polym"},{"issue":"1","key":"22_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.molmed.2005.11.004","volume":"12","author":"PV Escrib\u00e1","year":"2006","unstructured":"Escrib\u00e1 PV (2006) Membrane-lipid therapy: a new approach in molecular medicine. Trends Mol Med 12(1):34\u201343. https:\/\/doi.org\/10.1016\/j.molmed.2005.11.004","journal-title":"Trends Mol Med"},{"issue":"4","key":"22_CR27","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.1021\/nl500618u","volume":"14","author":"RH Fang","year":"2014","unstructured":"Fang RH, Hu CM, Luk BT, Gao W, Copp JA, Tai Y, O\u2019Connor DE, Zhang L (2014) Cancer cell membrane-coated nanoparticles for anticancer vaccination and drug delivery. Nano Lett 14(4):2181\u20132188. https:\/\/doi.org\/10.1021\/nl500618u","journal-title":"Nano Lett"},{"key":"22_CR28","doi-asserted-by":"publisher","first-page":"5","DOI":"10.3389\/fchem.2017.00005","volume":"5","author":"MR Fel\u00edcio","year":"2017","unstructured":"Fel\u00edcio MR, Silva ON, Gon\u00e7alves S, Santos NC, Franco OL (2017) Peptides with dual antimicrobial and anticancer activities. Front Chem 5:5. https:\/\/doi.org\/10.3389\/fchem.2017.00005","journal-title":"Front Chem"},{"key":"22_CR29","doi-asserted-by":"publisher","unstructured":"Feliu N, Walter MV, Monta\u00f1ez MI, Kunzmann A, Hult A, Nystr\u00f6m A et al (2012) Biomaterials 33(7):1970\u20131981. https:\/\/doi.org\/10.1016\/j.biomaterials.2011.11.054","DOI":"10.1016\/j.biomaterials.2011.11.054"},{"issue":"9","key":"22_CR30","doi-asserted-by":"publisher","first-page":"345","DOI":"10.3390\/metabo10090345","volume":"10","author":"C Ferreri","year":"2020","unstructured":"Ferreri C, Sansone A, Ferreri R, Am\u00e9zaga J, Tueros I (2020) Fatty acids and membrane lipidomics in oncology: a cross-road of nutritional, signaling and metabolic pathways. Metabolites 10(9):345. https:\/\/doi.org\/10.3390\/metabo10090345","journal-title":"Metabolites"},{"issue":"3","key":"22_CR31","doi-asserted-by":"publisher","first-page":"a004838","DOI":"10.1101\/cshperspect.a004838","volume":"3","author":"T Fujimoto","year":"2011","unstructured":"Fujimoto T, Parton RG (2011) Not just fat: the structure and function of the lipid droplet. Cold Spring Harb Perspect Biol 3(3):a004838. https:\/\/doi.org\/10.1101\/cshperspect.a004838","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"22_CR32","doi-asserted-by":"publisher","first-page":"2232","DOI":"10.1039\/C6MD00376A","volume":"7","author":"G Gabernet","year":"2016","unstructured":"Gabernet G, M\u00fcller AT, Hiss JA, Schneider G (2016) Membranolytic anticancer peptides. MedChemComm 7:2232\u20132245. https:\/\/doi.org\/10.1039\/C6MD00376A","journal-title":"MedChemComm"},{"issue":"1","key":"22_CR33","doi-asserted-by":"publisher","first-page":"5e000573","DOI":"10.1136\/bmjonc-2024-000573","volume":"4","author":"AA Gabizon","year":"2025","unstructured":"Gabizon AA, Gabizon-Peretz S, Modaresahmadi S, La-Beck NM (2025) Thirty years from FDA approval of pegylated liposomal doxorubicin (Doxil\/Caelyx): an updated analysis and future perspective. BMJ Oncol 4(1):5e000573. https:\/\/doi.org\/10.1136\/bmjonc-2024-000573","journal-title":"BMJ Oncol"},{"key":"22_CR34","doi-asserted-by":"publisher","first-page":"294","DOI":"10.3389\/fmicb.2013.00294","volume":"4","author":"D Gaspar","year":"2013","unstructured":"Gaspar D, Veiga AS, Castanho MARB (2013) From antimicrobial to anticancer peptides. A review. Front Microbiol 4:294. https:\/\/doi.org\/10.3389\/fmicb.2013.00294","journal-title":"Front Microbiol"},{"key":"22_CR35","doi-asserted-by":"publisher","unstructured":"Gavas S, Quazi S, Karpi\u0144ski TM (2021) Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett 16(173). https:\/\/doi.org\/10.1186\/s11671-021-03628-6","DOI":"10.1186\/s11671-021-03628-6"},{"issue":"5","key":"22_CR36","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1083\/jcb.137.5.1161","volume":"137","author":"NR Gough","year":"1997","unstructured":"Gough NR, Fambrough DM (1997) Different steady state subcellular distributions of the three splice variants of lysosome-associated membrane protein LAMP-2 are determined largely by the COOH-terminal amino acid residue. J Cell Biol 137(5):1161\u20131169. https:\/\/doi.org\/10.1083\/jcb.137.5.1161","journal-title":"J Cell Biol"},{"issue":"8","key":"22_CR37","doi-asserted-by":"publisher","first-page":"1263","DOI":"10.1093\/annonc\/mdl104","volume":"17","author":"MR Green","year":"2006","unstructured":"Green MR, Manikhas GM, Orlov S, Afanasyev B, Makhson AM, Bhar P et al (2006) Abraxane\u00ae, a novel Cremophor\u00ae-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer. Ann Oncol 17(8):1263\u20131268. https:\/\/doi.org\/10.1093\/annonc\/mdl104","journal-title":"Ann Oncol"},{"issue":"2","key":"22_CR38","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1016\/j.jconrel.2012.08.020","volume":"163","author":"M Han","year":"2012","unstructured":"Han M, Lv Q, Tang XJ, Hu YL, Xu DH, Li FZ et al (2012) Overcoming drug resistance of MCF-7\/ADR cells by altering intracellular distribution of doxorubicin via MVP knockdown with a novel siRNA polyamidoamine-hyaluronic acid complex. J Control Release 163(2):136\u2013144. https:\/\/doi.org\/10.1016\/j.jconrel.2012.08.020","journal-title":"J Control Release"},{"issue":"1","key":"22_CR39","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100(1):57\u201370. https:\/\/doi.org\/10.1016\/S0092-8674(00)81683-9","journal-title":"Cell"},{"key":"22_CR40","doi-asserted-by":"publisher","unstructured":"Hilchie AL, Hoskin DW, Power Coombs MR (2019) Anticancer activities of natural and synthetic peptides. Adv Exp Med Biol 1117:131\u2013147. https:\/\/doi.org\/10.1007\/978-981-13-3588-4_9","DOI":"10.1007\/978-981-13-3588-4_9"},{"key":"22_CR41","doi-asserted-by":"publisher","first-page":"656851","DOI":"10.3389\/fonc.2021.656851","volume":"11","author":"A Hip\u00f3lito","year":"2021","unstructured":"Hip\u00f3lito A, Martins F, Mendes C, Lopes-Coelho F, Serpa J (2021) Molecular and metabolic reprogramming: pulling the strings toward tumor metastasis. Front Oncol 11:656851. https:\/\/doi.org\/10.3389\/fonc.2021.656851","journal-title":"Front Oncol"},{"issue":"8","key":"22_CR42","doi-asserted-by":"publisher","first-page":"4607","DOI":"10.1073\/pnas.95.8.4607","volume":"95","author":"SK Hobbs","year":"1998","unstructured":"Hobbs SK, Monsky WL, Yuan F, Roberts WG, Griffith L, Torchilin VP et al (1998) Regulation of transport pathways in tumor vessels: role of tumor type and microenvironment. Proc Natl Acad Sci USA 95(8):4607\u20134612. https:\/\/doi.org\/10.1073\/pnas.95.8.4607","journal-title":"Proc Natl Acad Sci USA"},{"issue":"4","key":"22_CR43","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1021\/bc049962b","volume":"15","author":"S Hong","year":"2004","unstructured":"Hong S, Bielinska AU, Mecke A, Keszler B, Beals JL, Shi X et al (2004) Interaction of poly(amidoamine) dendrimers with supported lipid bilayers and cells: hole formation and the relation to transport. Bioconjug Chem 15(4):774\u2013782. https:\/\/doi.org\/10.1021\/bc049962b","journal-title":"Bioconjug Chem"},{"issue":"1","key":"22_CR44","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.nano.2014.09.006","volume":"11","author":"NK Jain","year":"2015","unstructured":"Jain NK, Tare MS, Mishra V, Tripathi PK (2015) The development, characterization and in vivo anti-ovarian cancer activity of poly(propylene imine) (PPI)-antibody conjugates containing encapsulated paclitaxel. Nanomed Nanotechnol Biol Med 11(1):207\u2013218. https:\/\/doi.org\/10.1016\/j.nano.2014.09.006","journal-title":"Nanomed Nanotechnol Biol Med"},{"issue":"11","key":"22_CR45","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1038\/nrclinonc.2010.139","volume":"7","author":"RK Jain","year":"2010","unstructured":"Jain RK, Stylianopoulos T (2010) Delivering nanomedicine to solid tumors. Nat Rev Clin Oncol 7(11):653\u2013664. https:\/\/doi.org\/10.1038\/nrclinonc.2010.139","journal-title":"Nat Rev Clin Oncol"},{"issue":"2","key":"22_CR46","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1021\/acsaenm.3c00675","volume":"2","author":"A Jaisingh","year":"2024","unstructured":"Jaisingh A, Nebhani L (2024) Dendrimers and hyperbranched polymers as promising and versatile additives in polyolefins. ACS Appl Eng Mater 2(2):236\u2013261. https:\/\/doi.org\/10.1021\/acsaenm.3c00675","journal-title":"ACS Appl Eng Mater"},{"issue":"20","key":"22_CR47","doi-asserted-by":"publisher","first-page":"2001119","DOI":"10.1002\/adom.202001119","volume":"8","author":"G Jiang","year":"2020","unstructured":"Jiang G, Li C, Liu X, Chen Q, Li X, Gu X et al (2020) Lipid droplet-targetable fluorescence guided photodynamic therapy of cancer cells with an activatable AIE-active fluorescent probe for hydrogen peroxide. Adv Opt Mater 8(20):2001119. https:\/\/doi.org\/10.1002\/adom.202001119","journal-title":"Adv Opt Mater"},{"issue":"3","key":"22_CR48","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3109\/21691401.2016.1160912","volume":"45","author":"A Kaur","year":"2017","unstructured":"Kaur A, Jain K, Mehra NK, Jain NK (2017) Development and characterization of surface engineered PPI dendrimers for targeted drug delivery. Artif Cells Nanomed Biotechnol 45(3):414\u2013425. https:\/\/doi.org\/10.3109\/21691401.2016.1160912","journal-title":"Artif Cells Nanomed Biotechnol"},{"issue":"11","key":"22_CR49","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1007\/s11095-007-9415-0","volume":"24","author":"KM Kitchens","year":"2007","unstructured":"Kitchens KM, Foraker AB, Kolhatkar RB, Swaan PW, Ghandehari H (2007) Endocytosis and interaction of poly (amidoamine) dendrimers with Caco-cells. Pharm Res 24(11):2138\u20132145. https:\/\/doi.org\/10.1007\/s11095-007-9415-0","journal-title":"Pharm Res"},{"issue":"2","key":"22_CR50","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1021\/mp700089s","volume":"5","author":"KM Kitchens","year":"2008","unstructured":"Kitchens KM, Kolhatkar RB, Swaan PW, Ghandehari H (2008) Endocytosis inhibitors prevent poly(amidoamine) dendrimer internalization and permeability across Caco-2 cells. Mol Pharm 5(2):364\u2013369. https:\/\/doi.org\/10.1021\/mp700089s","journal-title":"Mol Pharm"},{"issue":"15","key":"22_CR51","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1016\/j.addr.2005.09.016","volume":"57","author":"H Kobayashi","year":"2005","unstructured":"Kobayashi H, Brechbiel MW (2005) Nano-sized MRI contrast agents with dendrimer cores. Adv Drug Deliv Rev 57(15):2271\u20132286. https:\/\/doi.org\/10.1016\/j.addr.2005.09.016","journal-title":"Adv Drug Deliv Rev"},{"key":"22_CR52","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1038\/s41416-019-0650-z","volume":"122","author":"N Koundouros","year":"2019","unstructured":"Koundouros N, Poulogiannis G (2019) Reprogramming of fatty acid metabolism in cancer. Br J Cancer 122:4\u201322. https:\/\/doi.org\/10.1038\/s41416-019-0650-z","journal-title":"Br J Cancer"},{"issue":"12","key":"22_CR53","doi-asserted-by":"publisher","first-page":"5317","DOI":"10.1158\/0008-5472.CAN-04-3921","volume":"65","author":"JF Kukowska-Latallo","year":"2005","unstructured":"Kukowska-Latallo JF, Candido KA, Cao Z, Nigavekar SS, Majoros IJ, Thomas TP et al (2005) Nanoparticle targeting of anticancer drug improves therapeutic response in animal model of human epithelial cancer. Cancer Res 65(12):5317\u20135324. https:\/\/doi.org\/10.1158\/0008-5472.CAN-04-3921","journal-title":"Cancer Res"},{"issue":"1","key":"22_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15226\/sojmid.2013.00112","volume":"2","author":"G Laverty","year":"2014","unstructured":"Laverty G, Gilmore B (2014) Cationic antimicrobial peptide cytotoxicity. SOJ Microbiol Infect Dis 2(1):1\u20138. https:\/\/doi.org\/10.15226\/sojmid.2013.00112","journal-title":"SOJ Microbiol Infect Dis"},{"issue":"11","key":"22_CR55","doi-asserted-by":"publisher","first-page":"591","DOI":"10.3390\/pharmaceutics11110591","volume":"11","author":"NTT Le","year":"2019","unstructured":"Le NTT, Nguyen TNQ, Cao VDu, Hoang DT, Ngo VC, Thi TTH (2019) Recent progress and advances of multi-stimuli-responsive dendrimers in drug delivery for cancer treatment. Pharmaceutics 11(11):591. https:\/\/doi.org\/10.3390\/pharmaceutics11110591","journal-title":"Pharmaceutics"},{"key":"22_CR56","doi-asserted-by":"publisher","first-page":"1353626","DOI":"10.3389\/fphar.2024.1353626","volume":"15","author":"C Li","year":"2024","unstructured":"Li C, Li T, Tian X, An W, Wang Z, Han B et al (2024) Research progress on the PEGylation of therapeutic proteins and peptides (TPPs). Front Pharmacol 15:1353626. https:\/\/doi.org\/10.3389\/fphar.2024.1353626","journal-title":"Front Pharmacol"},{"key":"22_CR57","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.canlet.2017.05.002","volume":"401","author":"Q Liu","year":"2017","unstructured":"Liu Q, Luo Q, Halim A, Song G (2017) Targeting lipid metabolism of cancer cells: a promising therapeutic strategy for cancer. Cancer Lett 401:39\u201345. https:\/\/doi.org\/10.1016\/j.canlet.2017.05.002","journal-title":"Cancer Lett"},{"key":"22_CR58","doi-asserted-by":"publisher","unstructured":"Lopes-Coelho F, Gouveia-Fernandes S, Serpa J (2018) Metabolic cooperation between cancer and non-cancerous stromal cells is pivotal in cancer progression. Tumor Biol 40(2). https:\/\/doi.org\/10.1177\/1010428318756203","DOI":"10.1177\/1010428318756203"},{"key":"22_CR59","doi-asserted-by":"publisher","unstructured":"Martins F, Arada R, Barros H, Matos P, Ramalho J, Ce\u00f1a V, Bonif\u00e1cio VDB, Gon\u00e7alves LG, Serpa J (2025) Lactate-coated polyurea-siRNA dendriplex: a gene therapy-directed and metabolism-based strategy to impair glioblastoma (GBM). Cancer Gene Ther. https:\/\/doi.org\/10.1038\/s41417-025-00906-8.","DOI":"10.1038\/s41417-025-00906-8"},{"issue":"12 Pt1","key":"22_CR60","first-page":"6387","volume":"46","author":"Y Matsumura","year":"1986","unstructured":"Matsumura Y, Maeda H (1986) A new concept for macromolecular therapeutics in cancer chemotherapy: mechanism of tumoritropic accumulation of proteins and the antitumor agent smancs. Cancer Res 46(12 Pt1):6387\u20136392","journal-title":"Cancer Res"},{"issue":"12","key":"22_CR61","doi-asserted-by":"publisher","first-page":"1571","DOI":"10.1002\/anie.199215711","volume":"31","author":"H-B Mekelburger","year":"1992","unstructured":"Mekelburger H-B, V\u00f6gtle F, Jaworek W (1992) Dendrimers, arborols, and cascade molecules: breakthrough into generations of new materials. Angew Chemie Int Ed 31(12):1571\u20131576. https:\/\/doi.org\/10.1002\/anie.199215711","journal-title":"Angew Chemie Int Ed"},{"issue":"9","key":"22_CR62","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.3390\/molecules22091401","volume":"22","author":"LP Mendes","year":"2017","unstructured":"Mendes LP, Pan J, Torchilin VP (2017) Dendrimers as nanocarriers for nucleic acid and drug delivery in cancer therapy. Molecules 22(9):1401. https:\/\/doi.org\/10.3390\/molecules22091401","journal-title":"Molecules"},{"issue":"5-6","key":"22_CR63","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.drudis.2010.01.009","volume":"15","author":"AR Menjoge","year":"2010","unstructured":"Menjoge AR, Kannan RM, Tomalia DA (2010) Dendrimer-based drug and imaging conjugates: design considerations for nanomedical applications. Drug Discovery Today 15(5-6):171\u2013185. https:\/\/doi.org\/10.1016\/j.drudis.2010.01.009","journal-title":"Drug Discovery Today"},{"issue":"4","key":"22_CR64","doi-asserted-by":"publisher","first-page":"99","DOI":"10.2147\/ijn.s3061","volume":"2009","author":"E Miele","year":"2009","unstructured":"Miele E, Spinelli GP, Miele E, Tomao F, Tomao S (2009) Albumin-bound formulation of paclitaxel (Abraxane\u00ae ABI-007) in the treatment of breast cancer. Int J Nanomed 2009(4):99\u2013105. https:\/\/doi.org\/10.2147\/ijn.s3061","journal-title":"Int J Nanomed"},{"issue":"2","key":"22_CR65","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1021\/cr400362r","volume":"114","author":"S Mignani","year":"2014","unstructured":"Mignani S, El Kazzouli S, Bousmina M, Majoral JP (2014) Dendrimer space exploration: an assessment of dendrimers\/dendritic scaffolding as efficient drug and gene delivery nano-platforms. Chem Rev 114(2):1327\u20131342. https:\/\/doi.org\/10.1021\/cr400362r","journal-title":"Chem Rev"},{"key":"22_CR116","doi-asserted-by":"publisher","unstructured":"Mignani S, El Kazzouli S, Bousmina M, Majoral J-P (2013) Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview. Adv Drug Del Rev 65(10):1316-1330. https:\/\/doi.org\/10.1016\/j.addr.2013.01.001","DOI":"10.1016\/j.addr.2013.01.001"},{"issue":"1","key":"22_CR66","doi-asserted-by":"publisher","first-page":"50","DOI":"10.37349\/etat.2022.00071","volume":"3","author":"S Mignani","year":"2022","unstructured":"Mignani S, Shi X, Bryszewska M, Shcharbin D, Majoral JP (2022) Engineered phosphorus dendrimers as powerful non-viral nanoplatforms for gene delivery: a great hope for the future of cancer therapeutics. Explor Target Anti-tumor Ther 3(1):50\u201361. https:\/\/doi.org\/10.37349\/etat.2022.00071","journal-title":"Explor Target Anti-tumor Ther"},{"issue":"40","key":"22_CR67","doi-asserted-by":"publisher","first-page":"9772","DOI":"10.1021\/acs.jpcb.4c04152","volume":"128","author":"S Mitra","year":"2024","unstructured":"Mitra S, Chen MT, Stedman F, Hernandez J, Kumble G, Kang X et al (2024) How unnatural amino acids in antimicrobial peptides change interactions with lipid model membranes. J Phys Chem B 128(40):9772\u20139784. https:\/\/doi.org\/10.1021\/acs.jpcb.4c04152","journal-title":"J Phys Chem B"},{"issue":"3","key":"22_CR68","doi-asserted-by":"publisher","first-page":"1685","DOI":"10.3390\/ijms23031685","volume":"23","author":"D Mundekkad","year":"2022","unstructured":"Mundekkad D, Cho WC (2022) Nanoparticles in clinical translation for cancer therapy. Int J Mol Sci 23(3):1685. https:\/\/doi.org\/10.3390\/ijms23031685","journal-title":"Int J Mol Sci"},{"issue":"10","key":"22_CR69","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.3390\/ph15101283","volume":"15","author":"OA Musaimi","year":"2022","unstructured":"Musaimi OA, Lombardi L, Williams DR, Albericio F (2022) Strategies for improving peptide stability and delivery. Pharmaceuticals 15(10):1283. https:\/\/doi.org\/10.3390\/ph15101283","journal-title":"Pharmaceuticals"},{"key":"22_CR70","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s13738-020-02053-3","volume":"18","author":"F Najafi","year":"2020","unstructured":"Najafi F, Salami-Kalajahi M, Roghani-Mamaqani H (2020) A review on synthesis and applications of dendrimers. J Iran Chem Soc 18:503\u2013517. https:\/\/doi.org\/10.1007\/s13738-020-02053-3","journal-title":"J Iran Chem Soc"},{"issue":"1","key":"22_CR71","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.ijpharm.2006.11.047","volume":"336","author":"M Najlah","year":"2007","unstructured":"Najlah M, Freeman S, Attwood D, D\u2019Emanuele A (2007) In vitro evaluation of dendrimer prodrugs for oral drug delivery. Int J Pharm 336(1):183\u2013190. https:\/\/doi.org\/10.1016\/j.ijpharm.2006.11.047","journal-title":"Int J Pharm"},{"issue":"10","key":"22_CR72","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1021\/acs.bioconjchem.6b00437","volume":"27","author":"Y Nakamura","year":"2016","unstructured":"Nakamura Y, Mochida A, Choyke PL, Kobayashi H (2016) Nano-drug delivery: is the enhanced permeability and retention (EPR) effect sufficient for curing cancer?. Bioconjug Chem 27(10):2225\u20132238. https:\/\/doi.org\/10.1021\/acs.bioconjchem.6b00437","journal-title":"Bioconjug Chem"},{"issue":"16","key":"22_CR73","doi-asserted-by":"publisher","first-page":"12931","DOI":"10.3390\/ijms241612931","volume":"24","author":"NTT Nh\u00e0n","year":"2023","unstructured":"Nh\u00e0n NTT, Yamada T, Yamada KH (2023) Peptide-based agents for cancer treatment: current applications and future directions. Int J Mol Sci 24(16):12931. https:\/\/doi.org\/10.3390\/ijms241612931","journal-title":"Int J Mol Sci"},{"issue":"5","key":"22_CR74","doi-asserted-by":"publisher","first-page":"e09394","DOI":"10.1016\/j.heliyon.2022.e09394","volume":"8","author":"H Nsairat","year":"2022","unstructured":"Nsairat H, Khater D, Sayed U, Odeh F, Al Bawab A, Alshaer W (2022) Liposomes: structure, composition, types, and clinical applications. Heliyon 8(5):e09394. https:\/\/doi.org\/10.1016\/j.heliyon.2022.e09394","journal-title":"Heliyon"},{"key":"22_CR75","doi-asserted-by":"publisher","first-page":"114415","DOI":"10.1016\/j.addr.2022.114415","volume":"188","author":"N Pandey","year":"2022","unstructured":"Pandey N, Anastasiadis P, Carney CP, Kanvinde PP, Woodworth GF, Winkles JA et al (2022) Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment. Adv Drug Deliv Rev 188:114415. https:\/\/doi.org\/10.1016\/j.addr.2022.114415","journal-title":"Adv Drug Deliv Rev"},{"issue":"22","key":"22_CR76","doi-asserted-by":"publisher","first-page":"4369","DOI":"10.3390\/polym15224369","volume":"15","author":"M P\u00e9rez-Ferreiro M","year":"2023","unstructured":"P\u00e9rez-Ferreiro M M, Abelairas A, Criado A, G\u00f3mez IJ, Mosquera J (2023) Dendrimers: exploring their wide structural variety and applications. Polymers 15(22):4369. https:\/\/doi.org\/10.3390\/polym15224369","journal-title":"Polymers"},{"key":"22_CR77","doi-asserted-by":"publisher","first-page":"5197","DOI":"10.1039\/D2BM00679K","volume":"10","author":"SN Pinto","year":"2022","unstructured":"Pinto SN, Mil-Homens D, Pires RF, Alves MM, Serafim G, Martinho N et al (2022) Core-shell polycationic polyurea pharmadendrimers: new-generation of sustainable broad-spectrum antibiotics and antifungals. Biomater Sci 10:5197\u20135207. https:\/\/doi.org\/10.1039\/D2BM00679K","journal-title":"Biomater Sci"},{"key":"22_CR78","doi-asserted-by":"publisher","first-page":"101879","DOI":"10.1016\/j.jddst.2020.101879","volume":"59","author":"N Rabiee","year":"2020","unstructured":"Rabiee N, Ahmadvand S, Ahmadi S, Fatahi Y, Dinarvand R, Bagherzadeh M et al (2020) Carbosilane dendrimers: drug and gene delivery applications. J Drug Deliv Sci Technol 59:101879. https:\/\/doi.org\/10.1016\/j.jddst.2020.101879","journal-title":"J Drug Deliv Sci Technol"},{"issue":"3","key":"22_CR79","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1111\/febs.14281","volume":"285","author":"U Ray","year":"2018","unstructured":"Ray U, Roy SS (2018) Aberrant lipid metabolism in cancer cells\u2014the role of oncolipid-activated signaling. FEBS J 285(3):432\u2013443. https:\/\/doi.org\/10.1111\/febs.14281","journal-title":"FEBS J"},{"key":"22_CR80","doi-asserted-by":"publisher","first-page":"54872","DOI":"10.1039\/C4RA09603G","volume":"4","author":"RB Restani","year":"2014","unstructured":"Restani RB, Conde J, Baptista PV, Cidade MT, Bragan\u00e7a AM, Morgado J et al (2014) Polyurea dendrimer for efficient cytosolic siRNA delivery. RSC Adv 4:54872\u201354878. https:\/\/doi.org\/10.1039\/C4RA09603G","journal-title":"RSC Adv"},{"issue":"8","key":"22_CR81","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1002\/mabi.201500131","volume":"15","author":"RB Restani","year":"2015","unstructured":"Restani RB, Conde J, Pires RF, Martins P, Fernandes AR, Baptista PV et al (2015) POxylated polyurea dendrimers: Smart core-shell vectors with IC50 lowering capacity. Macromol Biosci 15(8):1045\u20131051. https:\/\/doi.org\/10.1002\/mabi.201500131","journal-title":"Macromol Biosci"},{"issue":"21","key":"22_CR82","doi-asserted-by":"publisher","first-page":"5162","DOI":"10.1002\/anie.201200362","volume":"51","author":"RB Restani","year":"2012","unstructured":"Restani RB, Morgado PI, Ribeiro MP, Correia IJ, Aguiar-Ricardo A, Bonif\u00e1cio VDB (2012) Biocompatible polyurea dendrimers with pH-dependent fluorescence. Angew Chemie Int Ed 51(21):5162\u20135165. https:\/\/doi.org\/10.1002\/anie.201200362","journal-title":"Angew Chemie Int Ed"},{"issue":"10","key":"22_CR83","doi-asserted-by":"publisher","first-page":"772","DOI":"10.1002\/open.201800093","volume":"7","author":"RB Restani","year":"2018","unstructured":"Restani RB, Pires RF, Tolmatcheva A, Cabral R, Baptista PV, Fernandes AR et al (2018) POxylated dendrimer-based nano-in-micro dry powder formulations for inhalation chemotherapy. ChemistryOpen 7(10):772\u2013779. https:\/\/doi.org\/10.1002\/open.201800093","journal-title":"ChemistryOpen"},{"issue":"8","key":"22_CR84","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/j.chemphyslip.2011.09.004","volume":"164","author":"S Riedl","year":"2011","unstructured":"Riedl S, Zweytick D, Lohner K (2011) Membrane-active host defense peptides\u2014challenges and perspectives for the development of novel anticancer drugs. Chem Phys Lipids 164(8):766\u2013781. https:\/\/doi.org\/10.1016\/j.chemphyslip.2011.09.004","journal-title":"Chem Phys Lipids"},{"key":"22_CR85","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-019-41903-w","volume":"9","author":"T Rivel","year":"2019","unstructured":"Rivel T, Ramseyer C, Yesylevskyy S (2019) The asymmetry of plasma membranes and their cholesterol content influence the uptake of cisplatin. Sci Rep 9: 5627. https:\/\/doi.org\/10.1038\/s41598-019-41903-w","journal-title":"Sci Rep"},{"issue":"1","key":"22_CR86","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1002\/(SICI)1097-4636(199601)30:1<53::AID-JBM8>3.0.CO;2-Q","volume":"30","author":"JC Roberts","year":"1996","unstructured":"Roberts JC, Bhalgat MK, Zera RT (1996) Preliminary biological evaluation of polyamidoamine (PAMAM) starburst dendrimers. J Biomed Mater Res 30(1):53\u201365","journal-title":"J Biomed Mater Res"},{"issue":"6","key":"22_CR87","doi-asserted-by":"publisher","first-page":"784","DOI":"10.3390\/biom12060784","volume":"12","author":"F Rodr\u00edguez","year":"2022","unstructured":"Rodr\u00edguez F, Caruana P, De la Fuente N, Espa\u00f1ol P, G\u00e1mez M, Balart J et al (2022) Nano-based approved pharmaceuticals for cancer treatment: present and future challenges. Biomolecules 12(6):784. https:\/\/doi.org\/10.3390\/biom12060784","journal-title":"Biomolecules"},{"issue":"8","key":"22_CR88","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.2174\/138920111796117300","volume":"12","author":"EV Rosca","year":"2011","unstructured":"Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS (2011) Anti-angiogenic peptides for cancer therapeutics. Curr Pharm Biotechnol 12(8):1101\u20131016. https:\/\/doi.org\/10.2174\/138920111796117300","journal-title":"Curr Pharm Biotechnol"},{"issue":"10","key":"22_CR89","doi-asserted-by":"publisher","first-page":"2523","DOI":"10.3390\/nu11102523","volume":"11","author":"I Santos","year":"2019","unstructured":"Santos I, Ramos C, Mendes C, Sequeira CO, Tom\u00e9 CS, Fernandes DGH et al (2019) Targeting glutathione and cystathionine \u03b2-synthase in ovarian cancer treatment by selenium-chrysin polyurea dendrimer nanoformulation. Nutrients 11(10):2523. https:\/\/doi.org\/10.3390\/nu11102523","journal-title":"Nutrients"},{"issue":"2","key":"22_CR90","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/2040-2384-2-14","volume":"11","author":"H Sarin","year":"2010","unstructured":"Sarin H (2010) Physiologic upper limits of pore size of different blood capillary types and another perspective on the dual pore theory of microvascular permeability. J Angiogenes Res 11(2):14. https:\/\/doi.org\/10.1186\/2040-2384-2-14","journal-title":"J Angiogenes Res"},{"key":"22_CR91","doi-asserted-by":"publisher","unstructured":"Serpa J (2020) Metabolic remodeling as a way of adapting to tumor microenvironment (TME), a job of several holders. Adv Exp Med Biol 1219:1\u201334. https:\/\/doi.org\/10.1007\/978-3-030-34025-4_1","DOI":"10.1007\/978-3-030-34025-4_1"},{"issue":"45","key":"22_CR92","doi-asserted-by":"publisher","first-page":"44826","DOI":"10.1074\/jbc.m308643200","volume":"278","author":"ND Sonawane","year":"2003","unstructured":"Sonawane ND, Szoka FC, Verkman AS (2003) Chloride accumulation and swelling in endosomes enhances DNA transfer by polyamine-DNA polyplexes. J Biol Chem 278(45):44826\u201344831. https:\/\/doi.org\/10.1074\/jbc.m308643200","journal-title":"J Biol Chem"},{"issue":"4","key":"22_CR93","doi-asserted-by":"publisher","first-page":"421","DOI":"10.4155\/tde.13.8","volume":"4","author":"T Stylianopoulos","year":"2013","unstructured":"Stylianopoulos T (2013) EPR-effect: utilizing size-dependent nanoparticle delivery to solid tumors. Ther Deliv 4(4):421\u2013423. https:\/\/doi.org\/10.4155\/tde.13.8","journal-title":"Ther Deliv"},{"issue":"5","key":"22_CR94","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1007\/s10863-020-09846-4","volume":"52","author":"W Szlasa","year":"2020","unstructured":"Szlasa W, Zendran I, Zalesi\u0144ska A, Tarek M, Kulbacka J (2020) Lipid composition of the cancer cell membrane. J Bioenerg Biomembr 52(5):321\u2013342. https:\/\/doi.org\/10.1007\/s10863-020-09846-4","journal-title":"J Bioenerg Biomembr"},{"issue":"3","key":"22_CR95","doi-asserted-by":"publisher","first-page":"427","DOI":"10.3390\/biom10030427","volume":"10","author":"A Szwed","year":"2020","unstructured":"Szwed A, Mi\u0142owska K, Michlewska S, Moreno S, Shcharbin D, Gomez-Ramirez R et al (2020) Generation dependent effects and entrance to mitochondria of hybrid dendrimers on normal and cancer neuronal cells in vitro. Biomolecules 10(3):427. https:\/\/doi.org\/10.3390\/biom10030427","journal-title":"Biomolecules"},{"issue":"1-2","key":"22_CR96","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/s0378-5173(00)00679-7","volume":"215","author":"F Tajarobi","year":"2001","unstructured":"Tajarobi F, El-Sayed M, Rege BD, Polli JE, Ghandehari H (2001) Transport of poly amidoamine dendrimers across Madin-Darby canine kidney cells. Int J Pharm 215(1-2):263\u2013267. https:\/\/doi.org\/10.1016\/s0378-5173(00)00679-7","journal-title":"Int J Pharm"},{"issue":"7","key":"22_CR97","doi-asserted-by":"publisher","first-page":"2316","DOI":"10.1128\/AAC.01488-05","volume":"50","author":"JE Thwaite","year":"2006","unstructured":"Thwaite JE, Hibbs S, Titball RW, Atkins TP (2006) Proteolytic degradation of human antimicrobial peptide LL-37 by Bacillus anthracis may contribute to virulence. Antimicrob Agents Chemother 50(7):2316\u20132322. https:\/\/doi.org\/10.1128\/AAC.01488-05","journal-title":"Antimicrob Agents Chemother"},{"key":"22_CR98","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1295\/polymj.17.117","volume":"17","author":"DA Tomalia","year":"1985","unstructured":"Tomalia DA, Baker H, Dewald J, Hall M, Kallos G, Martin S et al (1985) A new class of polymers: starburst-dendritic macromolecules. Polym J 17:117\u2013132. https:\/\/doi.org\/10.1295\/polymj.17.117","journal-title":"Polym J"},{"issue":"11","key":"22_CR99","doi-asserted-by":"publisher","first-page":"6108","DOI":"10.3390\/ijms23116108","volume":"23","author":"GE Valenti","year":"2022","unstructured":"Valenti GE, Alfei S, Caviglia D, Domenicotti C, Marengo B (2022) Antimicrobial peptides and cationic nanoparticles: a broad-spectrum weapon to fight multi-drug resistance not only in bacteria. Int J Mol Sci 23(11):6108. https:\/\/doi.org\/10.3390\/ijms23116108","journal-title":"Int J Mol Sci"},{"key":"22_CR100","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nrm2330","volume":"9","author":"G van Meer","year":"2008","unstructured":"van Meer G, Voelker D, Feigenson G (2008) Membrane lipids: where they are and how they behave. Nat Rev Mol Cell Biol 9:112\u2013124. https:\/\/doi.org\/10.1038\/nrm2330","journal-title":"Nat Rev Mol Cell Biol"},{"key":"22_CR101","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.actbio.2019.05.022","volume":"94","author":"AM Wagner","year":"2019","unstructured":"Wagner AM, Knipe JM, Orive G, Peppas NA (2019) Quantum dots in biomedical applications. Acta Biomater 94:44\u201363. https:\/\/doi.org\/10.1016\/j.actbio.2019.05.022","journal-title":"Acta Biomater"},{"issue":"1","key":"22_CR102","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1186\/s12951-022-01605-4","volume":"20","author":"S Waheed","year":"2022","unstructured":"Waheed S, Li Z, Zhang F, Chiarini A, Armato U, Wu J (2022) Engineering nano-drug biointerface to overcome biological barriers toward precision drug delivery. J Nanobiotechnol 20(1):395. https:\/\/doi.org\/10.1186\/s12951-022-01605-4","journal-title":"J Nanobiotechnol"},{"issue":"5\u20136","key":"22_CR103","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1016\/j.cdp.2009.01.001","volume":"32","author":"FL Wang","year":"2009","unstructured":"Wang FL, Cui SX, Sun LP, Qu XJ, Xie YY, Zhou L et al (2009) High expression of alpha 2,3-linked sialic acid residues is associated with the metastatic potential of human gastric cancer. Cancer Detect Prev 32(5\u20136):437\u2013443. https:\/\/doi.org\/10.1016\/j.cdp.2009.01.001","journal-title":"Cancer Detect Prev"},{"key":"22_CR104","doi-asserted-by":"publisher","unstructured":"Wang J, Li B, Qiu L, Qiao X, Yang H (2022) Dendrimer-based drug delivery systems: history, challenges, and latest developments. J Biol Eng 16(18). https:\/\/doi.org\/10.1186\/s13036-022-00298-5","DOI":"10.1186\/s13036-022-00298-5"},{"key":"22_CR105","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1039\/C4BM00365A","volume":"3","author":"M Wang","year":"2015","unstructured":"Wang M, Wang Y, Hu K, Shao N, Cheng Y (2015) Tumor extracellular acidity activated \u201coff\u2013on\u201d release of bortezomib from a biocompatible dendrimer. Biomater Sci 3:480\u2013489. https:\/\/doi.org\/10.1039\/C4BM00365A","journal-title":"Biomater Sci"},{"issue":"11","key":"22_CR106","doi-asserted-by":"publisher","first-page":"4252","DOI":"10.1021\/ja00011a031","volume":"113","author":"KL Wooley","year":"1991","unstructured":"Wooley KL, Hawker CJ, Fr\u00e9chet JMJ (1991) Hyperbranched macromolecules via a novel double-stage convergent growth approach. J Am Chem Soc 113(11):4252\u20134261. https:\/\/doi.org\/10.1021\/ja00011a031","journal-title":"J Am Chem Soc"},{"key":"22_CR118","doi-asserted-by":"publisher","unstructured":"Wu LP, Ficker M, Christensen JB et al (2021) Dendrimer end-terminal motif-dependent evasion of human complement and complement activation through IgM hitchhiking. Nat Commun 12(1):4858. https:\/\/doi.org\/10.1038\/s41467-021-24960-6","DOI":"10.1038\/s41467-021-24960-6"},{"issue":"22","key":"22_CR107","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.2217\/nnm-2016-0244","volume":"11","author":"L Xu","year":"2016","unstructured":"Xu L, Kittrell S, Yeudall WA, Yang H (2016) Folic acid-decorated polyamidoamine dendrimer mediates selective uptake and high expression of genes in head and neck cancer cells. Nanomedicine 11(22):2959\u20132973. https:\/\/doi.org\/10.2217\/nnm-2016-0244","journal-title":"Nanomedicine"},{"issue":"8","key":"22_CR108","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1248\/bpb.29.1547","volume":"29","author":"A Yamaji-Hasegawa","year":"2006","unstructured":"Yamaji-Hasegawa A, Tsujimoto M (2006) Asymmetric distribution of phospholipids in biomembranes. Biol Pharm Bull 29(8):1547\u20131553. https:\/\/doi.org\/10.1248\/bpb.29.1547","journal-title":"Biol Pharm Bull"},{"issue":"2","key":"22_CR109","doi-asserted-by":"publisher","first-page":"248","DOI":"10.3390\/pharmaceutics16020248","volume":"16","author":"S Yan","year":"2024","unstructured":"Yan S, Na J, Liu X, Wu P (2024) Different targeting ligands-mediated drug delivery systems for tumor therapy. Pharmaceutics 16(2):248. https:\/\/doi.org\/10.3390\/pharmaceutics16020248","journal-title":"Pharmaceutics"},{"issue":"2","key":"22_CR110","doi-asserted-by":"publisher","first-page":"219","DOI":"10.18388\/abp.2017_2331","volume":"65","author":"H Yao","year":"2018","unstructured":"Yao H, Ma J (2018) Dendrimer-paclitaxel complexes for efficient treatment in ovarian cancer: study on OVCAR-3 and HEK293T cells. Acta Biochim Pol 65(2):219\u2013225. https:\/\/doi.org\/10.18388\/abp.2017_2331","journal-title":"Acta Biochim Pol"},{"key":"22_CR111","doi-asserted-by":"publisher","first-page":"1463088","DOI":"10.3389\/fonc.2024.1463088","volume":"14","author":"H Zare-Zardini","year":"2024","unstructured":"Zare-Zardini H, Saberian E, Jen\u010da A, Ghanipour-Meybodi R, Petr\u00e1\u0161ov\u00e1 A, Jen\u010dov\u00e1 J (2024) From defense to offense: antimicrobial peptides as promising therapeutics for cancer. Front Oncol 14:1463088. https:\/\/doi.org\/10.3389\/fonc.2024.1463088","journal-title":"Front Oncol"},{"issue":"11","key":"22_CR112","doi-asserted-by":"publisher","first-page":"3677","DOI":"10.2147\/ijn.s106418","volume":"3","author":"J Zhang","year":"2016","unstructured":"Zhang J, Liu D, Zhang M, Sun Y, Zhang X, Guan G et al (2016) The cellular uptake mechanism, intracellular transportation, and exocytosis of polyamidoamine dendrimers in multidrug-resistant breast cancer cells. Int J Nanomed 3(11):3677\u20133690. https:\/\/doi.org\/10.2147\/ijn.s106418","journal-title":"Int J Nanomed"},{"key":"22_CR113","doi-asserted-by":"publisher","first-page":"937406","DOI":"10.3389\/fimmu.2022.937406","volume":"13","author":"M Zhang","year":"2022","unstructured":"Zhang M, Wei T, Zhang X, Guo D (2022) Targeting lipid metabolism reprogramming of immunocytes in response to the tumor microenvironment stressor: a potential approach for tumor therapy. Front Immunol 13:937406. https:\/\/doi.org\/10.3389\/fimmu.2022.937406","journal-title":"Front Immunol"},{"issue":"1","key":"22_CR114","doi-asserted-by":"publisher","first-page":"74","DOI":"10.2174\/1871520617666170419143459","volume":"18","author":"N Zhao","year":"2017","unstructured":"Zhao N, Qin Y, Liu H, Cheng Z (2017) Tumor-targeting peptides: ligands for molecular imaging and therapy. Anticancer Agents Med Chem 18(1):74\u201386. https:\/\/doi.org\/10.2174\/1871520617666170419143459","journal-title":"Anticancer Agents Med Chem"},{"issue":"9","key":"22_CR115","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1007\/s00018-005-4527-3","volume":"62","author":"RFA Zwaal","year":"2005","unstructured":"Zwaal RFA, Comfurius P, Bevers EM (2005) Surface exposure of phosphatidylserine in pathological cells. Cell Mol Life Sci 62(9):971\u2013988. https:\/\/doi.org\/10.1007\/s00018-005-4527-3","journal-title":"Cell Mol Life Sci"}],"container-title":["Advances in Experimental Medicine and Biology","Cancer Metabolic Remodeling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-12166-0_22","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T11:17:14Z","timestamp":1783768634000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-12166-0_22"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032121653","9783032121660"],"references-count":117,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-12166-0_22","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"12 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}